New York Life's $807B Arm Tokenizes a High-Yield Bond Fund

New York Life Investment Management is taking a high-yield bond strategy onchain. The firm, which oversees roughly $807 billion, has signed Centrifuge to tokenize its U.S. High Yield Corporate Bond Strategy under the ticker HYB. It is the manager's first tokenized product. Subscriptions and redemptions will settle in USDC.

A large manager breaks the pattern

The size is the story. Large asset managers have mostly watched tokenization from the sidelines, leaving smaller funds and DeFi-native shops to prove the model first. New York Life Investment Management breaks that pattern. This is a firm that runs money for New York Life's own general account and reaches everyday investors through financial advisors, and now it is putting a credit strategy on a public chain.

What tokenization actually changes

Tokenizing a bond fund does not change what it buys. The underlying portfolio and its risk controls stay with New York Life Investment Management. What changes is the plumbing. Centrifuge's platform handles issuance, settlement, and investor access onchain, which can cut the paperwork and settlement lag that slow traditional fund subscriptions and reach investors who sat outside the fund's usual distribution.

"Tokenization represents a compelling evolution in how investment solutions can be accessed, managed and distributed across both public and private markets," said Thomas Sy, who heads multi-asset solutions at the firm. Anil Sood, chief strategy officer and co-founder of Centrifuge Labs, said HYB fills a gap that existing onchain products do not. Centrifuge has been collecting these relationships for a while, and counts Apollo and Janus Henderson among its partners.

Access still limited to accredited investors

For now, HYB is open only to eligible investors, the familiar asterisk on products that advertise global reach. Industry analysts expect tokenized fixed income to expand over the next decade as institutions chase lower operating costs and wider distribution. The open question is whether a name like New York Life pulls the rest of the sidelined managers in.